|
|
One of the biggest investment opportunities over the next decade
will be in companies working to delay human death, a market expected
to be worth at least $600 billion by 2025, according to Bank of
America
(May, 2019).
Bank of America analysts say companies are on the cusp of "bringing
unprecedented increases to the quality and length of human lifespans."
Bank of America believe innovation in
"ammortality" products in the wellness space,
could soon prolong healthy human life well beyond 100 years.
"Medical knowledge will double every 73 days by 2020 vs. every 3.5
(years) in 2010. This has enabled a new frontier in precision
medicine to further extend life expectancy , heralding a 'techmanity'
(technology meets humanity) revolution."
Extending human life to new bounds — long the domain of science
fiction novels — could increasingly be a compelling way to make
money in the public markets. With a market size already at $110
billion, the Bank of America team highlighted five key sub-themes:
Genomics
Genomics, or the study of the human genome, is expected to be a $41
billion industry by 2025 and will provide the "next generation of
gene editing technology offering potentially revolutionary advances
in prevention and disease treatments," Bank of America said.
'Ammortality'
The "ammortality" theme, expected to be worth $504 billion by
2025, "will help to improve health spans & [lifespans] to the
betterment of human vitality, enabling the world population to live
freer of disease rather than forever."
Big data/AI health
The growth of artificial intelligence combined with an ever-growing
body of health-care data should help researchers analyze pathology,
or the study of the causes and effects of diseases, in the years to
come.
Future food
Future of food companies, which are expected to ensure healthier
eating and sustainable humanity on the planet.
'Moonshot medicine'
"Moonshot medicine" companies are those that offer revolutionary
solutions for cures or treatments for some of humanity's toughest
diseases -such as Alzheimer's.
Licensing
Territory: USA and Canada
Over the last 25 years, our parent Institute (Dr Perry Zeus's
Behavioral Coaching Institute) has become the world’s leading
developer of advanced, cutting-edge, coaching technology.
The
Institute's Neuro Clinic
cannot keep pace with the huge, rapidly expanding U.S.A and Canadian
anti-aging markets
so we have built an International Partner Program to help train highly
qualified individuals or businesses to deliver the program in their
region.
Note: We use an easier Licensing Format
rather than a Franchise model to assign regional rights to our Program and Brand.
We award licenses
based on the size of the
market that one License Holder is best qualified to service.
USA and
Canadian
Market
FRANCHISE
Reuters Editorial News “Global Anti-Aging Market Research Report”
The Anti-Aging Market is worth an estimated $275 billion and
is one of the rising markets
in today’s world. The USA and Canadian markets are the fastest
growing and biggest markets in the
world.
A Master License for one country or large region of a country has the right to re-sell and assign
territories within
their region to individual License Holders.
The
License Fee depends upon the size of the region.
Our Licensed Partners all have one thing common and that is their love of learning and helping people succeed.
If you think you have the know how for what it takes to succeed, then
this opportunity may still be
there for you to start helping people build a better tomorrow in your region.
Are you ready to
become an accredited
anti aging change agent and meet
the explosive growth in demand for affordable, proven solutions
to age reversal??
Click the below Registration Form Link to
book a telephone interview with Dr Zeus
to discuss details and find out if your preferred
local USA or Canadian territory
is available...
FRANCHISE OPPORTUNITY ANTI AGING |
|
|